Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients

FHS
May 24, 2024
5:19 pm

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute decompensated cirrhosis, and 2-26% in post-liver transplant patients.

National Science Foundation restores payments after five-day pause, but worries over science funding persist

On Sunday, the National Science Foundation announced that its payment system was back online to comply with a judge’s order, five days after the agency

February 2, 2025

Tocilizumab biosimilar by Bio-Thera Solutions for Rheumatoid Arthritis: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

August 30, 2023

Study finds digital CBT for children with anxiety delivers on par with traditional methods, lowers costs

If digitally augmented, therapist-supported, parent-led CBT is a cost-effective and clinically effective alternative.

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.